- Home
- ATXG vs QNRX Comparison
ATXG vs QNRX Comparison
Compare ATXG & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXG
- QNRX
- Stock Information
- Founded
- ATXG 2014
- QNRX 2018
- Country
- ATXG China
- QNRX United States
- Employees
- ATXG N/A
- QNRX N/A
- Industry
- ATXG Professional Services
- QNRX Medical/Dental Instruments
- Sector
- ATXG Consumer Discretionary
- QNRX Health Care
- Exchange
- ATXG Nasdaq
- QNRX Nasdaq
- Market Cap
- ATXG 4.0M
- QNRX 3.3M
- IPO Year
- ATXG N/A
- QNRX N/A
- Fundamental
- Price
- ATXG $0.60
- QNRX $9.60
- Analyst Decision
- ATXG
- QNRX
- Analyst Count
- ATXG 0
- QNRX 0
- Target Price
- ATXG N/A
- QNRX N/A
- AVG Volume (30 Days)
- ATXG 1.6M
- QNRX 12.9K
- Earning Date
- ATXG 08-13-2025
- QNRX 08-07-2025
- Dividend Yield
- ATXG N/A
- QNRX N/A
- EPS Growth
- ATXG N/A
- QNRX N/A
- EPS
- ATXG N/A
- QNRX N/A
- Revenue
- ATXG $4,549,310.00
- QNRX N/A
- Revenue This Year
- ATXG N/A
- QNRX N/A
- Revenue Next Year
- ATXG N/A
- QNRX N/A
- P/E Ratio
- ATXG N/A
- QNRX N/A
- Revenue Growth
- ATXG N/A
- QNRX N/A
- 52 Week Low
- ATXG $0.49
- QNRX $5.01
- 52 Week High
- ATXG $1.86
- QNRX $54.95
- Technical
- Relative Strength Index (RSI)
- ATXG 38.42
- QNRX 64.78
- Support Level
- ATXG $0.58
- QNRX $8.04
- Resistance Level
- ATXG $0.75
- QNRX $8.58
- Average True Range (ATR)
- ATXG 0.07
- QNRX 0.46
- MACD
- ATXG -0.01
- QNRX 0.04
- Stochastic Oscillator
- ATXG 5.19
- QNRX 98.57
About ATXG Addentax Group Corp.
Addentax Group Corp is an investment holding company. The company through its operating subsidiaries functions in the following segments; Garment manufacturing; Logistics services; Property management and subleasing. It generates maximum revenue from the Logistics services segment which provides logistics services including storage, transportation, warehousing, handling, packaging, and order processing. It also provides customs declaration and tax clearance services to its customers who export goods overseas. Geographically, the company derives all of its revenue from China.
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.